Increased PUFA content and 5-lipoxygenase pathway expression are associated with subcutaneous adipose tissue inflammation in obesewomen with type 2 diabetes

Nutrients

Volumn 7, Issue 9, 2015, Pages 7676-7690

  Heemskerk, Mattijs M ^a   Giera, Martin ^a   el Bouazzaoui, Fatiha ^a   Lips, Mirjam A ^a   Pijl, Hanno ^a   van Dijk, Ko Willems ^a   van Harmelen, Vanessa ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arachidonic acid; Gene expression; Leukotrienes; Lipidomics; Omega 3 fatty acids

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONIC ACID; CD68 ANTIGEN; DIPEPTIDASE; DIPEPTIDASE 2; DOCOSAHEXAENOIC ACID; LEUKOTRIENE B4; OXYLIPIN; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG; ALOX5 PROTEIN, HUMAN; ALOX5AP PROTEIN, HUMAN; AUTACOID; CD68 ANTIGEN, HUMAN; CNDP2 PROTEIN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; LEUKOTRIENE;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPID COMPOSITION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN EXPRESSION; SUBCUTANEOUS ADIPOSE TISSUE INFLAMMATION; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; ENZYMOLOGY; GENETICS; INTRAABDOMINAL FAT; MIDDLE AGED; NETHERLANDS; OBESITY, MORBID; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; UPREGULATION;

5-LIPOXYGENASE-ACTIVATING PROTEINS; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; DIABETES MELLITUS, TYPE 2; DIPEPTIDASES; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTRA-ABDOMINAL FAT; LEUKOTRIENES; MIDDLE AGED; NETHERLANDS; OBESITY, MORBID; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; UP-REGULATION;

EID: 84941354799     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7095362     Document Type: Article

References (33)

1. Hotamisligil, G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140, 900–917. [CrossRef] [PubMed]
2. Bluher, M. The distinction of metabolically “healthy” from “unhealthy” obese individuals. Curr. Opin. Lipidol. 2010, 21, 38–43. [CrossRef] [PubMed]
3. Rey-López, J.P.; de Rezende, L.F.; Pastor-Valero, M.; Tess, B.H. The prevalence of metabolically healthy obesity: A systematic review and critical evaluation of the definitions used. Obes. Rev. 2014, 15, 781–790.[CrossRef] [PubMed]
4. Van Beek, L.; Lips, M.A.; Visser, A.; Pijl, H.; Ioan-Facsinay, A.; Toes, R.; Berends, F.J.; Willems van Dijk, K.; Koning, F.; van Harmelen, V. Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism 2013, 63, 492–501. [CrossRef] [PubMed]
5. Dharuri, H.; t Hoen, P.A.; van Klinken, J.B.; Henneman, P.; Laros, J.F.; Lips, M.A.; el Bouazzaoui, F.; van Ommen, G.J.; Janssen, I.; van Ramshorst, B.; et al. Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss. Diabetologia 2014, 57, 2384–2392. [CrossRef] [PubMed]
6. Cinti, S.; Mitchell, G.; Barbatelli, G.; Murano, I.; Ceresi, E.; Faloia, E.; Wang, S.; Fortier, M.; Greenberg, A.S.; Obin, M.S. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 2005, 46, 2347–2355. [CrossRef] [PubMed]
7. Vachharajani, V.; Granger, D.N. Adipose tissue: A motor for the inflammation associated with obesity. IUBMB Life 2009, 61, 424–430. [CrossRef] [PubMed]
8. Masoodi, M.; Kuda, O.; Rossmeisl, M.; Flachs, P.; Kopecky, J. Lipid signaling in adipose tissue: Connecting inflammation & metabolism. Biochim. Biophys. Acta 2014, 1851, 503–518. [PubMed]
9. Jacobsson, L.; Lindgarde, F.; Manthorpe, R.; Akesson, B. Correlation of fatty acid composition of adipose tissue lipids and serum phosphatidylcholine and serum concentrations of micronutrients with disease duration in rheumatoid arthritis. Ann. Rheum. Dis. 1990, 49, 901–905. [CrossRef] [PubMed]
10. Korani, M.; Firoozrai, M.; Maleki, J.; Ghahramanpour, F.; Heidari, I.; Fallah, S.; Seifi, M. Distribution of fatty acids in adipose tissue of patients with type 2 diabetes. Clin. Lab. 2012, 58, 457–464. [PubMed]
11. Pezeshkian, M.; Mahtabipour, M.R. Epicardial and subcutaneous adipose tissue fatty acids profiles in diabetic and non-diabetic patients candidate for coronary artery bypass graft. BioImpacts 2013, 3, 83–89. [PubMed]
12. Masi, L.N.; Rodrigues, A.C.; Curi, R. Fatty acids regulation of inflammatory and metabolic genes. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16, 418–424. [CrossRef] [PubMed]
13. Vandanmagsar, B.; Youm, Y.H.; Ravussin, A.; Galgani, J.E.; Stadler, K.; Mynatt, R.L.; Ravussin, E.; Stephens, J.M.; Dixit, V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 17, 179–188. [CrossRef] [PubMed]
14. Simopoulos, A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. 2008, 233, 674–688. [CrossRef] [PubMed]
15. Tourdot, B.E.; Ahmed, I.; Holinstat, M. The emerging role of oxylipins in thrombosis and diabetes. Front. Pharmacol. 2014, 4, 176. [CrossRef] [PubMed]
16. Ricciotti, E.; FitzGerald, G.A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 986–1000. [CrossRef] [PubMed]
17. Fischer, R.; Konkel, A.; Mehling, H.; Blossey, K.; Gapelyuk, A.; Wessel, N.; von Schacky, C.; Dechend, R.; Muller, D.N.; Rothe, M.; et al. Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the cyp-epoxygenase pathway. J. Lipid Res. 2014, 55, 1150–1164. [CrossRef] [PubMed]
18. Von Moltke, J.; Trinidad, N.J.; Moayeri, M.; Kintzer, A.F.; Wang, S.B.; van Rooijen, N.; Brown, C.R.; Krantz, B.A.; Leppla, S.H.; Gronert, K. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 2012, 490, 107–111. [CrossRef] [PubMed]
19. Claria, J.; Nguyen, B.T.; Madenci, A.L.; Ozaki, C.K.; Serhan, C.N. Diversity of lipid mediators in human adipose tissue depots. Am. J. physiol. Cell physiol. 2013, 304, C1141–C1149. [CrossRef] [PubMed]
20. Balvers, M.G.; Verhoeckx, K.C.; Bijlsma, S.; Rubingh, C.M.; Meijerink, J.; Wortelboer, H.M.; Witkamp, R.F. Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues. Metabolomics 2012, 8, 1130–1147. [CrossRef] [PubMed]
21. Lips, M.A.; de Groot, G.H.; van Klinken, J.B.; Aarts, E.; Berends, F.J.; Janssen, I.M.; van Ramshorst, B.; van Wagensveld, B.A.; Swank, D.J.; van Dielen, F.; et al. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients. Clin. Endocrinol. 2014, 80, 834–842. [CrossRef]
22. Kloos, D.P.; Gay, E.; Lingeman, H.; Bracher, F.; Muller, C.; Mayboroda, O.A.; Deelder, A.M.; Niessen, W.M.; Giera, M. Comprehensive gas chromatography-electron ionisation mass spectrometric analysis of fatty acids and sterols using sequential one-pot silylation: Quantification and isotopologue analysis. Rapid Commun. Mass Spectrom. 2014, 28, 1507–1514.[CrossRef] [PubMed]
23. Heemskerk, M.M.; Dharuri, H.K.; van den Berg, S.A.; Jonasdottir, H.S.; Kloos, D.P.; Giera, M.; Willems van Dijk, K.; van Harmelen, V. Prolonged niacin treatment leads to increased adipose tissue poly-unsaturated fatty acid synthesis and an anti-inflammatory lipid and oxylipin plasma profile. J. Lipid Res. 2014, 55, 2532–2540. [CrossRef] [PubMed]
24. Jónasdóttir, H.; Ioan-Facsinay, A.; Kwekkeboom, J.; Brouwers, H.; Zuurmond, A.-M.; Toes, R.; Deelder, A.; Giera, M. An advanced LC–MS/MS platform for the analysis of specialized pro-resolving lipid mediators. Chromatographia 2014, 78, 391–401. [CrossRef]
25. Giera, M.; Ioan-Facsinay, A.; Toes, R.; Gao, F.; Dalli, J.; Deelder, A.M.; Serhan, C.N.; Mayboroda, O.A. Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS. Biochim. Biophys. Acta 2012, 1821, 1415–1424. [CrossRef] [PubMed]
26. Gonzalez-Periz, A.; Claria, J. Resolution of adipose tissue inflammation. ScientificWorldJournal 2010, 10, 832–856. [CrossRef] [PubMed]
27. Kaaman, M.; Ryden, M.; Axelsson, T.; Nordstrom, E.; Sicard, A.; Bouloumie, A.; Langin, D.; Arner, P.; Dahlman, I. ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance. Int. J. Obes. 2006, 30, 447–452. [CrossRef] [PubMed]
28. Martinez-Clemente, M.; Claria, J.; Titos, E. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14, 347–353. [CrossRef] [PubMed]
29. Mothe-Satney, I.; Filloux, C.; Amghar, H.; Pons, C.; Bourlier, V.; Galitzky, J.; Grimaldi, P.A.; Feral, C.C.; Bouloumie, A.; van Obberghen, E.; et al. Adipocytes secrete leukotrienes: Contribution to obesity-associated inflammation and insulin resistance in mice. Diabetes 2012, 61, 2311–2319. [CrossRef] [PubMed]
30. Murphy, R.C.; Gijon, M.A. Biosynthesis and metabolism of leukotrienes. Biochem. J. 2007, 405, 379–395. [CrossRef] [PubMed]
31. Claria, J.; Dalli, J.; Yacoubian, S.; Gao, F.; Serhan, C.N. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J. Immunol. 2012, 189, 2597–2605. [CrossRef] [PubMed]
32. Hellmann, J.; Tang, Y.; Kosuri, M.; Bhatnagar, A.; Spite, M. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 2011, 25, 2399–2407. [CrossRef] [PubMed]
33. Neuhofer, A.; Zeyda, M.; Mascher, D.; Itariu, B.K.; Murano, I.; Leitner, L.; Hochbrugger, E.E.; Fraisl, P.; Cinti, S.; Serhan, C.N.; et al. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes 2013, 62, 1945–1956. [CrossRef] [PubMed]